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The most important task after a total laryngectomy is rehabilitation of voice.
Tracheoesophageal speech with the use of valved silicone rubber prostheses gives
laryngectomized patients the immediate ability to restore their voice after surgery.
Tracheoesophageal speech is known to be superior to alternative methods, such as
esophageal speech and artificial laryngeal speech.
Indwelling tracheoesophageal voice prostheses need to be replaced clue to
leakage of esophageal fluids into the trachea or increased airflow resistance. Both
leakage and airflow resistance of a voice prosthesis are determined by both the de-
sign of the prosthesis, including the valve, and the clegree of colonization of the
esophageal side of the prosthesis by bacteria and yeast. This biofilm formation on
the esophageal site of the voice prostheses primarily detennines the device lifetime.
On average, proper functioning of these prostheses varies from 3 to 4 months, but in
some patients the device lifetime is remarkably shorter. Frequent replacements are
harmful to the tracheoesophageal fistula causing granulations, scar tissue formation
and insufficiency or stenosis of the fistula. Furthermore, frequent replacements are
unpleasant for the patients and can lead to high costs in health care.
Biofilm formation is a complex process starting from the mornent the voice pros-
thesis is placed in the tracheoesophageal fistula. Several internai and external factors
influence the formation of the biofilm, e.g. previous radiation, the microflora in the
neopharynx and dietary components. Due to its composition reduction of a biofilm
is difficult as microbial resistance is one of its survival mechanisms.
In this thesis several products capable to interfere in the biofilm formation
process are tested in vitro and in vivo and possibilities to increase the in situ lifetime
are discussed. The second aim is to irnprove the quality of life of laryngectomized
patients and to reduce the health care costs for this group of patients.
In Chapter 2 the artificial throat model was modified to a model comparable to
the clinical situation. As patients may consurne a food product immediately after re-
placement of a prosthesis, test products must be added from the onset of the biofilm
formation in the artificial throat in stead of on an existing biofilm. Buttermilk, Yakult
Light fermented milk drink and N-acetylcysteine prevented biofilm formation in
this artificial throat model. Next to their known reductive effect on biofilm forrna-
tion, these products are very promising for a clinical study to evaluate their effect on
the in situ lifetime of the voice prostheses.
In Chapter 3 the effect of buttermilk and Yakult Light fermented milk drink on
the lifetime of Provox@2 voice prostheses was tested both in vitro and in vivo. In
vitro results showed a reduction of bacteria in the biofilm, but a stimulation of the
amount of yeast. The in vivo part of the study showed a reduction of both bacteria
and yeast after consumption of Yakult Light fermented milk drink and, concurrent-
ly, a significant increase of the in situ lifetime. Buttermilk reduced only the amount
of yeast and stimulated bacterial growth. As a consequence, the in situ lifetime did
not significantly decrease. Although yeasts are considered to be responsible for
valve failure, a reduction of only the amount of yeast did not influence the in situ
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lifetime. This observation sulrports the theory that biofilm forrnation is a complex
process in which both bacteria and yeast play an important role and in which both
species are responsible for dysfunction of the voice prosthesis.
In Chapter 4 the influence of N-acetylcysteine on the integrity of the biofilm and
the in situ lifetime of Provox02 voice prostheses was assessed in vitro and ir-r vivo.
The importance of extracellular polymeric substances (EPS) or slime in the biofilm
was discussed. EPS glues the biofilm together ancl to the surface and is considered
to be responsible for the lack of influer-rce of antirnicrobial drugs on biofilm forma-
tion. N-acetylcysteine is a mucolytic drug which disrupts the disulfide bridges in
rrlucus anr'l therefore may disrupt the integrity of the biofilm. The biofilm on the
voice prostheses relnoved from the artificial throat showed a reduction of both bac-
teria and extracellular polymeric substances. In contrast to the in vitro study, the in
situ lifetime of the prostheses in the clinical part of the trial did not increase. As it is
generally known that a reduction of biofilm formation will positively effect the life-
time of tracheoesophageal voice prostl-reses, NAC still remains a promising drug for
the prolongation of the in situ lifetime. The negative effect on the lifetime is possible
a dose-related effect as it is known that a certain amount of biofilm is necessary to
seal of tl-re valve of the Provox'D2 prclsthesis. As dose-related effects of NAC have
been reported before, further research is necessary to determine the ideal dosage of
NAC in Provox@2 voice prostheses.
In Chapter 5 the effect of biofilm forrnation in Provox@2 voice prostheses on air-
flow parameters lvas evaluated in vivo by comparing airflow parameters of new
and of dysfunctional, biofilm covered Provox@2 voice prostheses, when the voice
prosthesis is in situ. The majority of patients needecl a new voice prosthesis because
of leakage through the voice prostheses and only 9% of tl're patients had problems
because of an increased airflow resistance. Previous in vitro studies showed an in-
creased airflow resistance as a conseguence of biofilm formation. ln this study in situ
rneasurements showed a significant clecrease of airflow resistance with a biofilm
present in relation to new clean voice prostheses without a biofilm present. The dis-
crepancy Lretween ex situ and in situ measurements can be explained because of the
multiplicity of factors in{luencing the voice and speech within patier-rts. In the spe-
cific patients group in which prosthesis replacement was necessary due to increased
phonatory efforts also decreased airflow resistances were measured. The major
cause of these remarkable results is obviously not found in a dysfunctional device
but may be explained by problems in the neopl'raryngeal pouch in relation to the
esophageal flange of the prosthesis. As aerodynamic problems only account for a
small part of the reasons for replacement of voice prostheses, reduction of biofilm
formation still remains a very relevant factor prolonging the in situ lifetime of voice
prostheses.
In Chapter 6 the Groningen frontloading system was clinically evaluated. The
aim of this study was twofold. First, to evaluate and validate a new, comfortable
method of insertion for the Groningen voice prostheses as compared to the Provox
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anterograde method. Second, to evaluate the lifetime of the Croningen Ultra Low
Resistance (ULR). With the use of structured questionnaires, the opinion of both pa-
tients and physicians about this new method and voice prosthesis was registered. In
tl-re majority of cases physicians were very pleasecl about the use of this new method,
and considered it adequate and friendly in use. The physicians preferred this new
method in84% of the patients. The patients reported no clifferences in cornfort com-
pared to the Provox anterograde method and no differences in effort to speak with
the Groningen ULR compared to the Provox@2. The lifetime of the Groningen ULR
was 150% of the lifetime of the Provox@2 and, as a consequence of these positive re-
sults, only 72% of the patients preferred the Provox@2 anterograde methoc'l. With
this new method a major reduction of health care costs can be achievecl as the cost of
a Groningen ULR is approximately one third of a Provox@2 and the in situ lifetime is
1.5 times the lifetime of a Provox@2. In conclusion, we created a frontloading system
comparable to the Provox@2 anterograde system and provided one standardized
rnethod of replacement for the Groningen Low Resistance and ULR voice prosthe-
ses. Important advantages of the Groningen frontloading system are a possible ma-
jor reduction of health care costs and an improvement of the quality of life of
laryngectomized patients by increasing the lifetime of their voice prostheses.
In Chapter 7, the general discussion of this thesis, the reasons to prolong the in
situ lifetime of voice prostheses is discussed. The need to explore other products in
stead of antimicrobial drugs to prevent biofilm formation is cliscussecl. Furthermore,
several suggestions are rnade to improve the quality of life of laryngectomized pa-
tients and to lower the health care costs for this specific patient group.
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